Subclinical atherosclerosis burden predicts cardiovascular events in individuals with diabetes and chronic kidney disease.
Ana PalancaEsmeralda CastelblancoÀngels BetriuHèctor PerpiñánBerta SoldevilaJosé Manuel ValdivielsoMarcelino Bermúdez-LopezCarlos Puig-JovéManel Puig-DomingoPer-Henrik GroopElvira FernándezNúria AlonsoEsmeralda CastelblancoPublished in: Cardiovascular diabetology (2019)
The burden of subclinical atherosclerosis is the strongest predictor of future CVEs in diabetic individuals with CKD. Early detection of subclinical atherosclerotic burden by multiterritorial vascular ultrasound could improve CVE prediction in this population.
Keyphrases
- cardiovascular events
- chronic kidney disease
- cardiovascular disease
- type diabetes
- coronary artery disease
- end stage renal disease
- risk factors
- magnetic resonance imaging
- computed tomography
- glycemic control
- metabolic syndrome
- wound healing
- insulin resistance
- ultrasound guided
- contrast enhanced ultrasound
- skeletal muscle